Milestone Pharmaceuticals Stock Forward View - Simple Moving Average
| MIST Stock | USD 1.94 0.07 3.48% |
Milestone Stock outlook is based on your current time horizon.
At this time, the value of RSI of Milestone Pharmaceuticals' share price is approaching 46. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Milestone Pharmaceuticals, making its price go up or down. Momentum 46
Impartial
Oversold | Overbought |
Using Milestone Pharmaceuticals hype-based prediction, you can estimate the value of Milestone Pharmaceuticals from the perspective of Milestone Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Moving Average forecasted value of Milestone Pharmaceuticals on the next trading day is expected to be 1.94 with a mean absolute deviation of 0.09 and the sum of the absolute errors of 5.16. Milestone Pharmaceuticals after-hype prediction price | USD 1.94 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Milestone | Build AI portfolio with Milestone Stock |
Milestone Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Milestone price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Milestone using various technical indicators. When you analyze Milestone charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Milestone Pharmaceuticals Simple Moving Average Price Forecast For the 30th of January
Given 90 days horizon, the Simple Moving Average forecasted value of Milestone Pharmaceuticals on the next trading day is expected to be 1.94 with a mean absolute deviation of 0.09, mean absolute percentage error of 0.02, and the sum of the absolute errors of 5.16.Please note that although there have been many attempts to predict Milestone Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Milestone Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Milestone Pharmaceuticals Stock Forecast Pattern
| Backtest Milestone Pharmaceuticals | Milestone Pharmaceuticals Price Prediction | Buy or Sell Advice |
Milestone Pharmaceuticals Forecasted Value
In the context of forecasting Milestone Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Milestone Pharmaceuticals' downside and upside margins for the forecasting period are 0.02 and 6.61, respectively. We have considered Milestone Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Milestone Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Milestone Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 110.2566 |
| Bias | Arithmetic mean of the errors | -0.0017 |
| MAD | Mean absolute deviation | 0.0875 |
| MAPE | Mean absolute percentage error | 0.0396 |
| SAE | Sum of the absolute errors | 5.16 |
Predictive Modules for Milestone Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Milestone Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Milestone Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Milestone Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Milestone Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Milestone Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Milestone Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Milestone Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Milestone Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Milestone Pharmaceuticals' historical news coverage. Milestone Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.10 and 6.61, respectively. We have considered Milestone Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Milestone Pharmaceuticals is dangerous at this time. Analysis and calculation of next after-hype price of Milestone Pharmaceuticals is based on 3 months time horizon.
Milestone Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Milestone Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Milestone Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Milestone Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.13 | 4.67 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.94 | 1.94 | 0.00 |
|
Milestone Pharmaceuticals Hype Timeline
Milestone Pharmaceuticals is now traded for 1.94. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Milestone is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is now at 0.13%. %. The volatility of related hype on Milestone Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 1.94. About 51.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.79. Milestone Pharmaceuticals had not issued any dividends in recent years. The entity had 1-1 split on the 24th of March 2020. Given the investment horizon of 90 days the next projected press release will be uncertain. Check out Historical Fundamental Analysis of Milestone Pharmaceuticals to cross-verify your projections. For more information on how to buy Milestone Stock please use our How to Invest in Milestone Pharmaceuticals guide.Milestone Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Milestone Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Milestone Pharmaceuticals' future price movements. Getting to know how Milestone Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Milestone Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RANI | Rani Therapeutics Holdings | 0.00 | 0 per month | 0.00 | (0.16) | 8.21 | (8.96) | 26.23 | |
| MOLN | Molecular Partners AG | 0.00 | 0 per month | 3.35 | 0.06 | 4.73 | (5.45) | 26.47 | |
| APLT | Applied Therapeutics | 0.00 | 0 per month | 0.00 | (0.21) | 10.00 | (15.73) | 83.66 | |
| CRDF | Cardiff Oncology | 0.00 | 0 per month | 0.00 | (0.07) | 9.28 | (6.82) | 45.59 | |
| ELTX | Elicio Therapeutics | 0.00 | 0 per month | 0.00 | (0.06) | 5.50 | (4.15) | 21.98 | |
| CYBN | Cybin Inc | 0.00 | 0 per month | 3.55 | (0.01) | 6.03 | (7.30) | 16.13 | |
| IPHA | Innate Pharma | 0.00 | 0 per month | 0.00 | (0.03) | 3.41 | (3.87) | 39.49 | |
| CRBP | Corbus Pharmaceuticals Holding | 0.00 | 0 per month | 0.00 | (0.16) | 4.60 | (6.85) | 16.04 | |
| SAVA | Cassava Sciences | 0.00 | 0 per month | 0.00 | (0.12) | 9.05 | (7.56) | 35.02 | |
| PEPG | PepGen | 0.00 | 0 per month | 5.79 | 0.05 | 10.14 | (9.08) | 25.08 |
Other Forecasting Options for Milestone Pharmaceuticals
For every potential investor in Milestone, whether a beginner or expert, Milestone Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Milestone Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Milestone. Basic forecasting techniques help filter out the noise by identifying Milestone Pharmaceuticals' price trends.Milestone Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Milestone Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Milestone Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Milestone Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Milestone Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Milestone Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Milestone Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Milestone Pharmaceuticals stock market strength indicators, traders can identify Milestone Pharmaceuticals entry and exit signals to maximize returns.
Milestone Pharmaceuticals Risk Indicators
The analysis of Milestone Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Milestone Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting milestone stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.22 | |||
| Semi Deviation | 4.17 | |||
| Standard Deviation | 4.67 | |||
| Variance | 21.82 | |||
| Downside Variance | 20.39 | |||
| Semi Variance | 17.35 | |||
| Expected Short fall | (4.05) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Milestone Pharmaceuticals
The number of cover stories for Milestone Pharmaceuticals depends on current market conditions and Milestone Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Milestone Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Milestone Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Milestone Pharmaceuticals Short Properties
Milestone Pharmaceuticals' future price predictability will typically decrease when Milestone Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Milestone Pharmaceuticals often depends not only on the future outlook of the potential Milestone Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Milestone Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 62.2 M | |
| Cash And Short Term Investments | 69.7 M |
Additional Tools for Milestone Stock Analysis
When running Milestone Pharmaceuticals' price analysis, check to measure Milestone Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Pharmaceuticals is operating at the current time. Most of Milestone Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Milestone Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Pharmaceuticals' price. Additionally, you may evaluate how the addition of Milestone Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.